Dolby Laboratories stock has had a difficult run over the past few years, yet the current checks on its share price suggest the valuation still leans on the cheap side rather than fully pricing in that weaker track record.

• Over the past 5 years, Dolby Laboratories shareholders have seen the stock fall about 46%, which means the market has already reset expectations quite a bit.
• Future cash generation from Dolby Laboratories' licensing model may support the current share price, while any sustained pressure on content volumes or device shipments remains a key risk for how much value those licenses can produce.
• On Simply Wall St's broader valuation checks, Dolby Laboratories scores 5 out of 6. This points to a stock that screens as undervalued on most measures rather than expensive.

The issue now is whether that apparent discount fairly reflects Dolby Laboratories' risks, or if the market has pushed the stock too far in response to the weaker long term return record.

Is Dolby Laboratories Still Cheap on Earnings?

The P/E ratio suits Dolby Laboratories because earnings remain a key anchor for a licensing driven business. The stock is currently trading on a P/E of about 19.1x, which is well below the broader software industry average of roughly 28.6x and also below the peer group average of about 39.2x. That already places Dolby Laboratories at a sizeable discount to many software stocks with similar business models.

Simply Wall St’s fair P/E ratio for Dolby Laboratories, which reflects factors like its margins, industry, size and risk profile, sits at around 22.5x. Set against the current 19.1x, this indicates the stock trades below the multiple implied by those fundamentals rather than stretching them. Taken together, the industry comparison and the fair ratio both point in the same direction.

On this earnings multiple, Dolby Laboratories stock appears undervalued compared with both its tailored fair P/E and the wider software sector.

The Dolby Laboratories Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Dolby Laboratories are designed to connect the current P/E based valuation puzzle with clear, scenario style views on what would need to happen to Dolby Laboratories' earnings, margins and growth for the stock to be worth materially more or less than today's price, and they sit on the company's Community page. Each narrative links its conclusion to a specific view of how Dolby Laboratories' growth, profitability and key risks might evolve, giving you something concrete to revisit as fresh information comes through.

One of the top community narratives on Dolby Laboratories: 45% undervalued

"Advancements in spatial audio, AI-driven sound processing, and developer tools like Dolby.io are set to catalyze new direct-to-consumer and enterprise SaaS revenue streams..."

Do you think there's more to the story for Dolby Laboratories? Head over to our Community to see what others are saying!

The Bottom Line

Dolby Laboratories now screens as undervalued on its P/E based checks, with the current multiple sitting below both sector averages and its own tailored fair ratio. That discount only really makes sense if the market is pricing in lasting pressure on content volumes or device shipments that would cap licensing earnings. For investors, the key question is whether those business risks remain entrenched or whether earnings prove resilient enough for the multiple to close some of the gap to peers.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.